South Korean benchmark Kospi jumped as much as 11% at the open. Overnight in the U.S., stocks rose, building on the momentum ...

China sets lowest growth target on record at 4.5% to 5%. War powers vote fails in the U.S. Senate. Iran targets Amazon's ...

The Foundation for Angelman Syndrome Therapeutics (FAST) has helped redefine the role of advocacy groups. Founded and led by ...

As scientific and political pressures collide at the FDA, regulatory bottlenecks are intensifying. At this critical and ...

The science behind rare disease treatments is advancing at an unprecedented pace. Biogen is sharpening its long-term strategy ...

Sarepta has come under scrutiny over Elevidys, its gene therapy for Duchenne Muscular Dystrophy (DMD). With a one-time ...

Anthropic AI is growing rapidly in usage among companies, but with the Trump administration declaring economic war on the ...

Texas Republican Rep. Tony Gonzales has come under fire for allegedly having a romantic relationship with a staffer who died ...

CNBC's Jim Cramer said the oil market may be signaling the war with Iran won't escalate into a prolonged disruption to crude ...

CNBC’s “Closing Bell Overtime” team discusses Nvidia's $30 billion OpenAI investment with Gene Munster of Deepwater Asset ...

The secretary saw a friendlier reception from House Republicans than she did from their Senate counterparts a day before.

Stocks rebounded on Wednesday, buoyed by gains in technology and semiconductor giants. Oil prices stabilized after this ...